Attending 5th Varian Oncology Summit 2019: Learning Experiences as a Medical Physicist

Authors

  • Venugopal Sudaram Senior Medical Physicist cum RSO Department of Radiation Oncology, Nepal Cancer Hospital and Research Center, Harisiddhi, Lalitpur, Nepal

Keywords:

IMRT, Medical Physicist, Radiation Oncologist, Varian, VMAT

Abstract

The main objective of the conference was to provide insights into new innovation and technology-related products by Varian to its global users, thus aiming to facilitate better and advance treatment to every cancer patients. Varian organized this summit to create a platform for its users to share their experience and knowledge not only in India but also the neighbouring country such as Nepal, Bangladesh, etc. The need for radiotherapy center in our country Nepal has been growing rapidly yet there are only a few radiotherapy centers with less or not enough needed technical resources and manpower (Radiation oncologists (ROs), Medical physicists (MPs), Radiotherapy Technologists (RTT’s)). Many radiotherapy centers still followed basic treatment modality only. However, due to the lack of high-end treatment techniques such as Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Radio Surgery (SRS) and Stereotactic Radio Therapy (SRT) in Nepal, it poses a great burden to patients as they have to travel outside the country to get better quality treatment.

Downloads

Download data is not yet available.
Abstract
102
pdf
100

Downloads

Published

2019-12-31

How to Cite

Sudaram, V. (2019). Attending 5th Varian Oncology Summit 2019: Learning Experiences as a Medical Physicist. Europasian Journal of Medical Sciences, 1(1), 72–74. Retrieved from https://nepjol.info./index.php/ejms/article/view/35592

Issue

Vol. 1 No. 1 (2019): Europasian Journal of Medical Sciences (EJMS) | 2019 (July - December) Issue 1

Section

Conference Reports

License

The author(s) retain the ownership of the copyrights for their work published in EJMS without any restrictions. Upon submission, the author(s) grants EJMS a license to publish, including to display, store, copy, and reuse the published content.

License to Publish
By submitting a manuscript to EJMS, the author(s) grant the journal a non-exclusive license to:

  • Publish and distribute the content in all formats, media, and platforms (both existing and future), while identifying EJMS as the original publisher.
  • Reproduce, display, and store the content in both print and online formats, including institutional and digital repositories.
  • Translate, adapt, and summarize the work, including reprints, extracts, and abstracts.
  • Develop derivative works based on the original content.
  • Include the work in electronic databases and provide links to third-party materials.

Creative Commons Licensing
In addition to EJMS’s publishing rights, authors grant third parties the right to use, share, and distribute their work under the Creative Commons Attribution 4.0 (CC BY 4.0) International License. This allows unrestricted use of the content, provided proper attribution is given to the original author(s) and the journal.